Home
About
Technology
Contact
More
In this horizontal test we accurately generate all antibody CDRs from scratch for 310 different Antibodies, including 60 approved therapeutic Antibodies.
Our Classifier module has a 95% success ratio predicting if an antibody binds a specific epitope for 310 different antigens.
We improve the binding affinity of an antibody targeting HER2, using Trastuzumab as starting point.